Correlation Between Pfizer and Summit Midstream

Can any of the company-specific risk be diversified away by investing in both Pfizer and Summit Midstream at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Summit Midstream into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Summit Midstream Partners, you can compare the effects of market volatilities on Pfizer and Summit Midstream and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Summit Midstream. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Summit Midstream.

Diversification Opportunities for Pfizer and Summit Midstream

-0.68

Correlation Coefficient

Pfizer  Summit Midstream

Excellent diversification

The 3 months correlation between Pfizer and Summit is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Summit Midstream Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Midstream Partners and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Summit Midstream. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Midstream Partners has no effect on the direction of Pfizer i.e., Pfizer and Summit Midstream go up and down completely randomly.

Pair Corralation between Pfizer and Summit Midstream

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.16 times more return on investment than Summit Midstream. However, Pfizer Inc is 6.21 times less risky than Summit Midstream. It trades about 0.01 of its potential returns per unit of risk. Summit Midstream Partners is currently generating about -0.01 per unit of risk. If you would invest  2,550  in Pfizer Inc on September 12, 2024 and sell it today you would earn a total of  7.00  from holding Pfizer Inc or generate 0.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	62.9%
Values	Daily Returns

Pfizer Inc  vs.  Summit Midstream Partners

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Summit Midstream Partners

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Midstream Partners has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable essential indicators, Summit Midstream is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Pfizer and Summit Midstream

The main advantage of trading using opposite Pfizer and Summit Midstream positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Summit Midstream can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Midstream will offset losses from the drop in Summit Midstream's long position.

The idea behind Pfizer Inc and Summit Midstream Partners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.